These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12394834)

  • 21. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD; Tadaki DK; Celniker A; Batty DS; Berning JD; Colonna JO; Cruzata F; Elster EA; Gray GS; Kampen RL; Patterson NB; Szklut P; Swanson J; Xu H; Harlan DM
    Transplantation; 2001 Aug; 72(3):377-84. PubMed ID: 11502964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.
    Chirmule N; Raper SE; Burkly L; Thomas D; Tazelaar J; Hughes JV; Wilson JM
    J Virol; 2000 Apr; 74(7):3345-52. PubMed ID: 10708452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.
    Lassiter G; Otsuka R; Hirose T; Rosales I; Karadagi A; Tomosugi T; Dehnadi A; Lee H; Colvin RB; Baardsnes J; Moraitis A; Smith EE; Ali Z; Berhe P; Mulder A; Meibohm B; Daugherty B; Fogarty S; Pierson RN; Lederman S; Kawai T
    Am J Transplant; 2023 Aug; 23(8):1171-1181. PubMed ID: 37019335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.
    Kenyon NS; Chatzipetrou M; Masetti M; Ranuncoli A; Oliveira M; Wagner JL; Kirk AD; Harlan DM; Burkly LC; Ricordi C
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8132-7. PubMed ID: 10393960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.
    Ferrant JL; Benjamin CD; Cutler AH; Kalled SL; Hsu YM; Garber EA; Hess DM; Shapiro RI; Kenyon NS; Harlan DM; Kirk AD; Burkly LC; Taylor FR
    Int Immunol; 2004 Nov; 16(11):1583-94. PubMed ID: 15466914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term therapy with anti-ICAM-1 monoclonal antibody induced long-term liver allograft survival in nonhuman primates.
    Hong SK; Han D; Lee SK; Kim J; Hwang ES; Kim H; Lee JI; Hong K; Han ES; Cho JH; Lee JM; Choi Y; Lee KW; Yi NJ; Yang J; Suh KS
    Am J Transplant; 2021 Sep; 21(9):2978-2991. PubMed ID: 33423374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
    Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
    Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primates.
    Lo DJ; Farris AB; Song M; Leopardi F; Anderson DJ; Strobert EA; Ramakrishnan S; Turgeon NA; Mehta AK; Turnbull B; Maroni B; Violette SM; Kirk AD
    Am J Transplant; 2013 Dec; 13(12):3085-93. PubMed ID: 24119188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
    McLigeyo SO; Notghi A; Anderton JL; Dick J
    East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
    Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
    Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
    Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.
    Miura S; Habibabady ZA; Pollok F; Ma M; Rosales IA; Kinoshita K; Pratts S; McGrath G; Chaban R; Fogarty S; Meibohm B; Daugherty B; Lederman S; Pierson RN
    Am J Transplant; 2023 Aug; 23(8):1182-1193. PubMed ID: 37030662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
    Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA
    Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates.
    Oura T; Yamashita K; Suzuki T; Fukumori D; Watanabe M; Hirokata G; Wakayama K; Taniguchi M; Shimamura T; Miura T; Okimura K; Maeta K; Haga H; Kubota K; Shimizu A; Sakai F; Furukawa H; Todo S
    Am J Transplant; 2012 Jul; 12(7):1740-54. PubMed ID: 22420525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.